Insight journal - Company

Partnering with Actavis: strengthening competitive position

Posted on 03 September 2013

Tags: ,

Actavis is a top pharma company active in partnering, licensing and M&A in pharmaceuticals.

Actavis’ global growth strategy is focused on three key principles:

  • internal product development
  • strategic alliances
  • select mergers/acquisitions of products, technologies and companies

As the company expands its Actavis Pharma and Actavis Specialty Brands businesses, with a focus on the U.S., Canada, and Latin America and other emerging markets, Actavis is committed to identifying opportunities that fit its capabilities, enhance its corporate goals and strengthen its competitive position.

Summary of Actavis partnering interests

Actavis splits its partnering interests into distinct areas.

These can be summarized as follows:

  • Branded – phase II or earlier
  • Branded – phase II or later, not approved
  • Branded – approved
  • Authorized generic
  • Generic
  • Active pharmaceutical ingredient

The company does not explicitly list the therapy areas of interest for partnering, however these can be assumed to be aligned with its existing generics business:

  • Antibiotics
  • Anti-inflammatories
  • Cardiovascular Diseases
  • Dermatology Products
  • Central Nervous System Disorders
  • Metabolic Disorders
  • Musculo-skeletal System Disorders
  • Respiratory System Treatments
  • Contraceptives
  • Genito-urinary Conditions
  • Women’s Health
  • Oncology Treatments
  • Pain Management
  • Smoking Cessation
  • Urology
  • Women’s health

For the latest detail on Actavis’s partnering interests, visit the partnering section of Actavis website  go to Business Development for details.

Partnering outreach

Actavis are routinely present at a large number of partnering events throughout the year.

Partnering events are a great place to meet lots of potential partners face to face in a small amount of time.

Events with Actavis presence include but are not limited to:

-        BIO International Convention and Business Forum

-        BioPartnering Future Europe / BioPartnering North America

-        BioEurope / BioEurope Spring

For a full list of forthcoming partnering events where you could meet with Actavis in person visit Current Partnering’s Event calendar.

In addition, you can find a full list of events where Actavis will be present for partnering discussions, visit the partnering section of Actavis website > go to Business Development for details.

Contacting Actavis for partnering

Actavis can be contacting in relation to partnering through a number of channels.

Here is a list of the most common channels:

Partnering events: face to face contact is generally considered the most effective form of contact. Partnering events not only allow face to face contact but also contact with multiple companies for the price of one flight and hotel reservation. This benefit makes partnering events the most cost effective method of making personal introductions as a start point for partnering discussions.

See Current Partnering’s event calendar for details of forthcoming events.

Direct contact: there are several sources of direct contact with Actavis business development team

-        Phone: Picking up the phone and speaking with an individual is the best form of non-face to face contact as it allows your name and voice to be remembered and associated with an opportunity.

-        Email: Sending an email is another good way of making contact. Ideally, research the individual responsible for the therapy/technology area being targeted and get in touch. Actavis do not publish a list of contacts on their website, so unless you cannot find a direct contact elsewhere use the contact form here.

-        LinkedIn: Business to business contact is increasingly taking place via LinkedIn, the global online networking channel. Many of Actavis business development executives have LinkedIn profiles and can be found by viewing the company’s profile. Visit Actavis LinkedIn page here

Opportunity submission form: the least favourable channel but worth using if you do not have access to the other channels mentioned above. Actavis provides an online opportunity submission form which can be found by partnering section of Actavis website > go to Business Development for details.


Summary profile data for Actavis

Partnering activity for Actavis

M&A activity for Actavis


Available reports from Current Partnering

Report: Partnering Agreements with Actavis (formerly Watson Pharmaceuticals) 2005-2013

Report: Top 50 Big Pharma Partnering and M&A Deal Trends


Available resources for deal coverage for Actavis

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Actavis / Watson company profile, recent partnering, M&A and financing news and articles



Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply